Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
11.8M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
179K
-
Shares change
-
+22.9K
-
Total reported value, excl. options
-
$956K
-
Value change
-
+$515K
-
Number of buys
-
8
-
Number of sells
-
-4
-
Price
-
$5.36
Significant Holders of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) as of Q4 2019
12 filings reported holding HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q4 2019.
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 179K shares
of 11.8M outstanding shares and own 1.52% of the company stock.
Largest 10 shareholders include BlackRock Inc. (60.6K shares), RENAISSANCE TECHNOLOGIES LLC (43K shares), OXFORD ASSET MANAGEMENT LLP (17.2K shares), Virtu Financial LLC (14.7K shares), GEODE CAPITAL MANAGEMENT, LLC (13.9K shares), Prospera Financial Services Inc (13.1K shares), DEUTSCHE BANK AG\ (7.03K shares), MORGAN STANLEY (3.52K shares), UBS Group AG (3.32K shares), and American Portfolios Advisors (2K shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.